Thanks for the link phillip_k
In the interview, I was a bit non-plussed by Leo Lee's comment that Regeneus intends "to start our phase 2 study in Japan in the near future, probably in 2021...". That's 2 years away and it seems a bit of a stretch to characterise that as "the near future". Given that the phase 1 work was completed in 2017, I'd have thought that the last 2 years would have been spent getting prepared for the phase 2 study, so that things would be ready to roll when a Progenza licensee in Japan was signed up.
Perhaps it is no longer intended that a prospective Progenza licensee would conduct the phase 2 study in Japan. Maybe the company intends to initiate the study itself - hence the divestment of the RGSH4K and animal health businesses - ie. to raise cash for working capital and to help fund the phase 2 Progenza study in Japan.
Of course I'm speculating here, but I did notice that in the interview, and in last Thursday's company advertising feature in the AFR there was not a word mentioned about seeking a prospective Progenza licensee in Japan. What was said in the advertising feature was that the company was a matter of "months away from finalising a "new partnership to distribute its knee osteoarthritis product".
Maybe I'm missing something quite important, but I'm struggling to see the need for a Progenza distributor in Japan, if the strategy remains to licence the use of the product to a specific company or companies in that country.
Anyway, I have asked the company for clarification, but thus far I remain waiting for a response to my queries.
zeno9
- Forums
- ASX - By Stock
- CMB
- Ann: Regeneus Appoints International Directors for Global Growth
Ann: Regeneus Appoints International Directors for Global Growth, page-12
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CMB (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.0¢ |
Change
-0.045(11.4%) |
Mkt cap ! $4.175M |
Open | High | Low | Value | Volume |
39.0¢ | 39.0¢ | 35.0¢ | $46 | 127 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 75 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 1910 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 75 | 0.355 |
1 | 1917 | 0.350 |
1 | 2500 | 0.200 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 1910 | 1 |
0.500 | 51 | 1 |
0.545 | 13403 | 1 |
0.600 | 2000 | 1 |
0.670 | 7238 | 1 |
Last trade - 13.58pm 09/08/2024 (20 minute delay) ? |
Featured News
CMB (ASX) Chart |